← Back
Data updated: Mar 10, 2026
MELINTA THERAP
Infectious DiseaseDermatologyCardiovascular
MELINTA THERAP is a specialty pharmaceutical company focused on Infectious Disease, Dermatology, Cardiovascular. Key products include ORBACTIV.
1992
Since
3
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 60%
2 drugs Phase 3: 2 Phase 2: 4 Phase 1: 3
Dermatology 29%
2 drugs Phase 2: 1 Phase 1: 1
Cardiovascular 12%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
COSETTE other
Cardiovascular, Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Cardiovascular